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Recently a new simply calculated index of body composition -a body shape index (ABSI) has been introduced as an
index more reliable than BMI of association between body composition and all-cause mortality. However, until now
associations between ABSI and metabolic risk factors have not been evaluated. A total of 114 male university students
not engaged in any planned physical activity participated in the present study. Anthropometric measurements (weight,
height, waist circumference) were recorded. Body mass index (BMI) was calculated from weight and height, body shape
index (ABSI) was calculated from waist circumference, weight, height and BMI. Blood was withdrawn after an overnight
fast from the antecubital vein. Triacylglycerols, total cholesterol and HDL-cholesterol levels in plasma were determined
using colorimetric methods and Randox commercial kits. Plasma LDL-cholesterol concentrations were calculated
according to the Friedewald formula. Circulating insulin was assayed using a standard radioimmunological method
with monoclonal antibodies against insulin and BioSource commercial kits. BMI was slightly, but significantly correlated
only with circulating TG (r=0.330, p < 0.001) In contrast, ABSI was slightly, but significantly correlated with plasma levels
of insulin (r=0.360, p<0.001), TC (r=0.270, p<0.002), LDL-C and non-HDL-C (r=0.300, p<0.001). In participants at the upper
quartile of BMI circulating TG was higher (by 50%, p<0.05) than in their counterparts at the lower BMI quartile. Subjects
representing the upper quartile of ABSI were characterized by higher plasma levels of insulin, TC, LDL-C and non-HDL
in comparison with subjects at the lower ABSI quartile. (by 92 %, 11. %, 29 % and 21 % respectively, p<0.001). ABSI, a
new simply calculated index of body fat seems to more accurately depict the variability in circulating insulin and
lipoproteins than BMI at least in young, healthy male subjects.
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At present obesity is recognized as the main cause of
type 2 diabetes, cardiovascular disease and an important
contributing factor in some cancers [1]. In consequence,
precise obesity criteria and diagnosis are of special im-
portance in medical practice.
There is a wide range of methods for body fat determin-
ation, which are suitable in laboratory practice (BIA,
DEXA, CT, and MRI); however, they require costly equip-
ment, which is not always available [2-4]. Much simpler
skinfold measurement are time-consuming and have to be
performed by experienced technicians [5]. Thus, they are
not suitable either for everyday medical practice or in* Correspondence: grazyna.lutoslawska@awf.edu.pl
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unless otherwise stated.population-based studies. According to WHO recommen-
dations, the body mass index (BMI) calculated from body
weight and height and waist circumference (WC) are a
valid indicators of fatness and this assumption has been
supported by many studies concerning their associations
with health risk [6-8]. On the other hand, there are data
questioning BMI reliability and indicating that it provides
a false diagnosis of body fatness [9,10]. There are also data
indicating that regional fat distribution, but not total body
fat stores, are related to metabolic disturbances and health
risks [11,12]. Furthermore, it has been demonstrated that
WHO standards of BMI are not suitable for the evaluation
of body fat with respect to ethnicity [13].
Similarly, many doubts exist with respect to associations
between BMI and mortality. Assuming that BMI provides
reliable information concerning body fatness and takingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and mortality, it is not clear why the BMI-mortality rela-
tionship is U-shaped, suggesting high mortality in both
lean and obese humans [14-16]. Moreover, it is worth not-
ing that in young healthy adults BMI, but also other surro-
gate indices of fatness (e.g. waist-to-height ratio, body
adiposity index) provide poor prognosis of fat mass since
they reflect mostly skeletal muscle mass [17,18].
In the literature there are many other simple surrogate
indices of body fat such as the waist-to-height ratio (e.g.
weight-to-height ratio-WtHR), conicity index - CI, body
adiposity index -BAI), however, their validity in respect
to BMI is still under debate [19-22]. Recently Krakauer
and Krakauer [23] proposed a new simply calculated
index of body composition (a body shape index - ABSI)
as more reliable than BMI in determination of associ-
ation between all-cause mortality and body composition.
However, data concerning relationship of ABSI with
health risk are controversial. ABSI was found to predict
resting blood pressure in adolescents more precisely
than BMI [24]. On the contrary, ABSI predictive ability
was not better than BMI with respect to type 2 diabetes,
hypertension and cardiovascular disease in Chinese and
Iranian populations [25-27]. The reason for this discrep-
ancy is unknown, however, it may be due to ethnic differ-
ences in body fat distribution [28]. In addition, it cannot
be excluded that BMI reflecting mostly total body fat dif-
fers in its relationship to metabolic variables from ABSI,
which encompasses waist circumference, thus at least par-
tially depicts fat distribution [29].
Thus, this study was undertaken and aimed at the
evaluation of the relationship between ABSI and BMI
and biochemical variables contributing to health risk in
sedentary young male adults.
Methods
Participants
We studied a sample of 114 male university students re-
cruited through word-of-mouth, and posters displayed at
the university and in student dormitories. They were se-
lected from 148 volunteers because they agreed to venous
blood withdrawal under fasting conditions. All participants
were healthy non-smokers not engaged in planned physical
activity and not taking any medication on a regular basis.
They were informed about procedures and all provided
their written consent. The study protocol was accepted by
the local ethics committee at the Jósef Piłsudski University
of Physical Education.
Anthropometric measurements
Body mass was measured to the nearest 0.1 kg and body
height to the nearest 0.5 cm using standard medical
equipment in subjects wearing light indoor clothing
without shoes, jackets and sweaters. Body mass index(BMI) was calculated as body mass (kg) divided by
height (m) squared. The subjects’ adiposity was classified
according to WHO standards: underweight was defined
as BMI < 18.5, normal weight as BMI ≥ 18.5 and <25,
overweight as BMI ≥ 25 to BMI <30, and obesity as a
BMI ≥30 [30]. Waist circumference (WC) was measured
in the midway section between the lower edge of the ribs
and the iliac crest with an accuracy of 0.1 cm using non-
stretchable tape and values <102 cm were accepted as
normal [30]. All measurements were performed twice
but in case of divergent results were repeated for the
third time. A Body Shape Index (ABSI) was calculated
according to Krakauer and Krakauer [23] and the follow-
ing formula:
ABSI ¼ WC mð Þ= BMI2=3  height mð Þ1=2
h i
Blood tests
Participants were asked to refrain from physical activity
for 48 h before blood sampling. They were tested in the
morning (8:00–8:30 a.m.) after an overnight fast. Venous
blood was collected under aseptic conditions into plastic
tubes containing anticoagulant and centrifuged at 4°C.
Plasma was stored at -70° until analysis.
Glucose was determined using the GOD-PAP method.
Circulating glucose was classified according to the Inter-
national Diabetes Federation with 5.5 mmol/l accepted as
the upper level [31]. Triacylglycerols (TG), total choles-
terol (TC), and HDL-cholesterol (HDL-C) were assayed
colorimetrically. All variables were determined using com-
mercial kits (Randox Laboratories, Great Britain). Coeffi-
cients of variation for these analyses did not exceed 5%.
The plasma level of LDL-cholesterol (LDL-C) was cal-
culated according to the Friedewald equation [32].
Non-HDL-cholesterol (non-HDL-C) was calculated by
subtraction of HDL-C from TC [33]. Concentrations of
plasma lipoproteins were classified according to recom-
mendations of the European Atherosclerosis Society and
European Guidelines on Cardiovascular Disease Prevention
in Clinical Practice (TG <1.7 mmol/l, TC < 4.5 mmol/l,
HLD-C >1.0 mmol/l, LDL-C < 2.5 mmol/l, non-HDL <
2.5 mmol/l [34,35]. Plasma insulin was assayed using a
standard radioimmunoassay with monoclonal antibodies
against insulin and commercial kits (BioSource, Belgium).
The sensitivity of the method was 1 μIU/ml, intra and
inter-assay coefficients of variation were 6.8% and 9.3%,
respectively. All analyses were run in duplicate.
Statistical analyses
Data are presented as mean ± SD. All variables were
checked for normality using the Shapiro-Wilk test. The
Pearson correlation coefficients were calculated for logarith-
mically (e-based) transformed data. Moreover, biochemical
Table 1 Anthropometric characteristics and biochemical
variables in young healthy men (means ± SD)
Variable n = 114
Age (years) 21.7 ± 1.4
Weight (kg) 77.2 ± 12.2
Height (cm) 180.3 ± 6.7
BMI 23.7 ± 3.3 (25.4)*
Waist (cm) 80.7 ± 8.9 (2.0)*
ABSI 0.073 ± 0.003
Glucose (mmol/l) 4.8 ± 0.5 (6.1)^
Insulin (μIU/ml) 10.5 ± 6.4
TG (mmol/l) 0.9 ± 0.4 (6.1)^
TC (mmol/l) 4.5 ± 0.8 (24.5)^
HDL-C (mmol/l) 1.4 ± 0.3 (8.8)^
LDL-C (mmol/l) 2.7 ± 0.7 (25.4)^
Non-HDL (mmol/l) 3.1 ± 0.8 (29.8)^
BMI – body mass index; ABSI- a body shape index; TG-triacylglycerols; TC-total
cholesterol; HDL-C- HDL- cholesterol; LDL-C – LDL-cholesterol;* percent of
participants with overweight and obesity; ^percent of participants with
disturbed biochemical variables.
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quartile of BMI and ABSI and the Mann–Whitney test was
used for data comparison. A p value ≤ 0.05 was considered
to be statistically significant. All calculations were carried
out using the Statistica v.7 (Statsoft, Illinois, USA).
Results
Baseline characteristics of the participants are presented
in Table 1. According to BMI standards 74.6% of partici-
pants were normal weight, 18.4% were overweight, and
7.0% were obese. Only 2.0% of our subjects were charac-
terized by higher than recommended waist circumference.
Circulating glucose and triacylglycerols were higher than
normal in similar percentages of students (6.1%). Slightly
more participants (8.8%) were characterized by lower than
normal HDL-cholesterol. On the contrary, higher than
normal TC, LDL-C and non-HDL-C were observed in
24.5%, 25.4% and 29.8% of participants, respectively.
BMI was slightly, but significantly correlated only with cir-
culating TG (r = 0.330, p < 0.001). On the contrary, ABSITable 2 Biochemical variables in young healthy men accordin
Variable Glucose Insulin TG
BMI
Q1 (20.0 ± 0.9) 4.8 ± 0.6 10.4 ± 7.2 0.8 ± 0.4
Q 4 (28.2 ± 2.8) 5.1 ± 0.4 10.5 ± 4.8 1.2 ± 0.5a
ABSI
Q1 (0.069 ± 0.001) 4.9 ± 0.5 7.2 ± 2.9 0.9 ± 0.4
Q 4 (0.077 ± 0.002) 4.9 ± 0.5 13.8 ± 7.6b 0.9 ± 0.4
For abbreviations see Table 1; Q1
, Q4 - lower and upper quartile, respectively;
aP < 0was slightly, but significantly correlated with plasma levels of
insulin (r = 0.360, p < 0.001), TC (r = 0.270, p < 0.002), LDL-
C and non-HDL-C (r = 0.300, p < 0.001) (data not shown).
In participants at the upper BMI quartile circulating TG
was higher (by 50%, p < 0.05) than in their counterparts at
the lower BMI quartile (Table 2). Subjects representing
the upper quartile of ABSI were characterized by higher
plasma levels of insulin, TC, LDL-C and non-HDL (by
92%, 11. %, 29% and 21%, respectively, p < 0.001) in com-
parison with subjects at the lower ABSI quartile.
Discussion
The most important finding of our study concerns ABSI,
which is better correlated to changes in circulating TC
and insulin than BMI in young sedentary men. It is
worth noting that the homogeneity of our participants
according to age and sex strengthens our findings. Add-
itionally, taking into account that disturbances in bio-
chemical parameters (insulin, glucose, and lipoproteins)
bring about health deteriorations, it could be tentatively
postulated that ABSI may be of importance in risk prog-
nosis of type 2 diabetes and/or atherogenesis [36]. On
the other hand, it should be stressed that ABSI validity
in the prognosis of cardiovascular disease (CVD) is far
from being elucidated since Maessen et al. [37] have not
found ABSI capable of determining the presence of this
disease in middle-aged subjects.
It should be stressed that in some way ABSI agrees with
the WHO recommendation concerning waist circumfer-
ence inclusion into health risk evaluation [30]. Similarly,
other authors have suggested that both BMI and WC con-
tribute to the prediction of body adiposity in white men
and women [38]. The importance of WC measurements
in diagnosis of health risk has been suggested by many
authors since it has been postulated that WC provides in-
direct information about visceral fat accumulation [39,40].
At present it is well documented that visceral fat due to
its location and metabolic characteristics contributes to
distorted metabolism to a much greater extent than
subcutaneous fat [41,42].
However, it is worth noting that mathematical correla-
tions between metabolic variables and surrogate indices ofg to lower and upper quartiles of BMI and ABSI
TC HDL-C LDL-C Non-HDL
4.5 ± 0.9 1.4 ± 0.3 2.7 ± 0.8 3.0 ± 08
4.5 ± 0.8 1.3 ± 0.3 2.7 ± 0.8 3.2 ± 0.8
4.3 ± 0.8 1.4 ± 0.2 2.4 ± 0.8 2.9 ± 0.8
4.8 ± 0.9 1.3 ± 0.3 3.1 ± 0.8b 3.5 ± 0.8b
.05; bP <0.001.
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effect relationship. On the other hand, marked differences
in metabolic profiles of subjects selected according to
lower and upper quartiles of ABSI may suggest that ABSI,
but not BMI, depicts variability in circulating insulin and
lipoproteins in participants of our study mostly character-
ized by normal body fat according to BMI standards.
Thus, it seems feasible that ABSI allows diagnosis of slight
metabolic disturbances observed in otherwise healthy sub-
jects [43,44]. In addition, assuming that lower and upper
quartiles of BMI varied by 41% (28.2 versus 20.0) and ABSI
quartiles differ by 11.6% (0.077 versus 0.069) it seems that
even minor changes in ABSI provide information about
variability in metabolic risk.
However, more studies are needed to prove this hypoth-
esis, because of limitations of our study: the low number
of participants from one social group, living in a big city,
and representing one sex and one ethnicity.
Conclusions
Our study evaluated relationships between two surrogate
measures of body composition – body mass index (BMI)
and a body shape index (ABSI) with blood biochemical
variables which contribute to health risk (glucose and
lipoproteins).
Participants classified according to lower and upper
quartile of ABSI markedly differ with respect to circulating
insulin, total cholesterol, LDL-cholesterol and non-HDL-
cholesterol. On the contrary, participants classified ac-
cording to lower and upper quartile of BMI slightly differ
exclusively with respect to circulating triacylglycerols.
Thus, in young and otherwise healthy sedentary men
ABSI is a better predictor than BMI of variability in bio-
chemical parameters, which may indicate disturbed meta-
bolic processes.
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